A carregar...
Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
SUMMARY: Bone mineral density response to once weekly delayed-release formulation of risedronate, given before or following breakfast, was non-inferior to that seen with traditional immediate-release risedronate given daily before breakfast. Delayed-release risedronate is a convenient dosing regimen...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer-Verlag
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3536960/ https://ncbi.nlm.nih.gov/pubmed/23079690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-012-2175-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|